loader image
Saturday, December 13, 2025
68.5 F
McAllen
- Advertisement -

A Simple Colonoscopy Can Save Your Life

Health & Lifestyle
334

Translate to Spanish or other 102 languages!

A routine screening for colorectal cancer beginning at age 45 can save lives! Image for illustration purposes
A routine screening for colorectal cancer beginning at age 45 can save lives! Image for illustration purposes

Mega Doctor News

- Advertisement -

By Texas Tech University Health Sciences Center El Paso

Newswise — A routine screening for colorectal cancer beginning at age 45 can save lives! In cancers that affect both men and women, colorectal cancer is the second leading cancer killer—but most cases can be prevented with routine screening tests.

Colorectal cancer usually starts from precancerous polyps in the colon or rectum. Over time, some polyps can turn into cancer.

- Advertisement -

Screening tests aid in finding precancerous polyps, so they can be removed before they turn into cancer. Screening tests can also find colorectal cancer early, when treatment works best.

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Nursing Grad Gets a Life Lesson In Compassion
Next article
Let The Patient Choose Their Type 2 Diabetes Meds

More Articles

Tips to Tame the ‘Sunday Scaries’

Weekends only last so long, and if you start feeling anxious by Sunday, you're not alone.

Watercress A Nutrient-Dense Leafy Green

Watercress is a leafy green that naturally grows in clean, slow-moving water and belongs to the same plant family as mustard greens, kale, and cabbage. It has a mild, peppery taste and can be eaten raw or cooked in many different meals.

Off-the-Shelf Immunotherapy Offers Hope for Aggressive Myeloma

A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in extramedullary multiple myeloma — one of the most aggressive and treatment-resistant forms of the disease. 

FDA Approves Zenflow Spring® System for BPH Treatment

 Zenflow, Inc. announced today the U.S. Food and Drug Administration (FDA) approval of the Zenflow Spring® Implant and Delivery System for the treatment of symptoms associated with benign prostatic hyperplasia (BPH), also known as enlarged prostate.
- Advertisement -

We feature articles about leading professionals in the medical and healthcare industry in the South Texas area. We are your connection to the medical community!

Pick up a copy of our publication on more than 800 locations Valley-wide.

Contact Us

Office (956) 928-1255

Sales (956) 451-4585

info@tbbmega.com

sales@tbbmega.com

Subscribe

© Mega Doctor News 2025

×